Oncotarget

Research Papers:

FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker

Valérie Gouazé-Andersson _, Marie-Julie Ghérardi, Anthony Lemarié, Julia Gilhodes, Vincent Lubrano, Florent Arnauduc, Elizabeth Cohen-Jonathan Moyal and Christine Toulas

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:31637-31649. https://doi.org/10.18632/oncotarget.25827

Metrics: PDF 582 views  |   HTML 925 views  |   ?  


Abstract

Valérie Gouazé-Andersson1, Marie-Julie Ghérardi1, Anthony Lemarié1, Julia Gilhodes2, Vincent Lubrano3, Florent Arnauduc1, Elizabeth Cohen-Jonathan Moyal1,2,* and Christine Toulas1,2,*

1Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1037/Université Toulouse III Paul Sabatier, Cancer Research Center of Toulouse (CRCT), Toulouse, F-31000, France

2Institut Claudius Regaud, IUCT-O, Toulouse, F-31059, France

3CHU PURPAN-Pavillon Baudot, Place du Dr Baylac, Toulouse-Cedex 3, 31024, France

*These authors contributed equally to this work

Correspondence to:

Valérie Gouazé-Andersson, email: valerie.gouaze-andersson@inserm.fr, gouaze@hotmail.com

Keywords: FGFR1; FOX; glioblastoma; radioresistance; prognosis biomarker

Received: April 28, 2018     Accepted: July 13, 2018     Published: August 03, 2018

ABSTRACT

Glioblastoma are known to be aggressive and therapy-resistant tumors, due to the presence of glioblastoma stem cells inside this heterogeneous tumor. We investigate here the involvement of FGFR1 in glioblastoma stem-like cells (GSLC) radioresistance mechanisms. We first demonstrated that the survival after irradiation was significantly diminished in FGFR1-silenced (FGFR1-) GSLC compared to control GSLC. The transcriptome analysis of GSLCs FGFR1(-) showed that FOX family members are differentially regulated by FGFR1 inhibition, particularly with an upregulation of FOXN3 and a downregulation of FOXM1. GSLC survival after irradiation was significantly increased after FOXN3 silencing and decreased after FOXM1 inhibition, showing opposite effects of FGFR1/FOX family members on cell response to ionizing radiation. Silencing FGFR1 or FOXM1 downregulated genes involved in mesenchymal transition such as GLI2, TWIST1, and ZEB1 in glioblastoma stem-like cells. It also dramatically reduced GSLC migration. Databases analysis confirmed that the combined expression of FGFR1/FOXM1/MELK/GLI2/ZEB1/TWIST1 is significantly associated with patients overall survival after chemo-radiotherapy treatment. All these results, associated with our previous conduced ones with differentiated cells, clearly established that FGFR1-FOXM1 dependent glioblastoma stem-like cells radioresistance pathway is a central actor of GBM treatment resistance and a key target to inhibit in the aim to increase the sensitivity of GBM to the radiotherapy.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25827